Stage I non-small cell lung cancer is an early form of lung cancer where the tumor is small and contained within the lung, making it one of the most treatable stages of the disease. Detecting lung cancer at this early point offers patients the best chance for successful treatment and long-term survival, though many cases go unnoticed because symptoms may not yet appear.

Introduction: Who Should Undergo Diagnostics

Understanding when to seek diagnostic testing for lung cancer can be life-saving. Stage I non-small cell lung cancer refers to a situation where abnormal cells have developed into cancer within the lung tissue, but the disease remains relatively small and has not yet traveled to nearby lymph nodes or distant parts of the body. This early detection window is crucial because treatment outcomes are significantly better when cancer is caught at this stage.^[1]

People who should consider diagnostic testing include those with specific risk factors or concerning symptoms. If you have a history of smoking, even if you quit years ago, you face an increased risk. Smoking remains the most significant risk factor for developing non-small cell lung cancer. However, it’s important to know that lung cancer can also occur in people who have never smoked.^[2]

Other risk factors that might warrant diagnostic evaluation include long-term exposure to asbestos, which commonly affected workers in construction, shipyards, and certain manufacturing industries. Exposure to radon gas, a naturally occurring radioactive substance that can accumulate in homes, also increases lung cancer risk. If you have a family history of lung cancer, have been exposed to metal and mineral dust in your workplace, or have existing respiratory conditions like pulmonary fibrosis (scarring of lung tissue) or COPD (chronic obstructive pulmonary disease), you may benefit from screening. People who received radiation therapy to the breast or chest area for previous medical conditions should also be vigilant.^[2]

Symptoms that should prompt you to see a doctor include a new cough that persists for three weeks or longer, a cough that becomes worse over time, or coughing up blood or blood-stained mucus. Other warning signs include chest pain, pain when breathing or coughing, shortness of breath that you can’t explain, hoarseness in your voice, ongoing tiredness, unexplained weight loss, or loss of appetite. Some people experience repeated respiratory infections like pneumonia or bronchitis that don’t improve with standard treatment.^[2]

Classic Diagnostic Methods

When doctors suspect lung cancer, they use several diagnostic methods to confirm the presence of cancer, determine its type, and understand how far it has spread. The diagnostic process typically begins with simpler tests and progresses to more detailed examinations as needed.

Your healthcare provider will start with a complete physical examination and take your medical history. They’ll ask about your symptoms, how long you’ve had them, your smoking history, occupational exposures, and any family history of cancer. This conversation helps them understand your overall health picture and level of risk.^[2]

Imaging Tests

Imaging studies are essential tools that allow doctors to see inside your body without surgery. A chest X-ray is often the first imaging test ordered when lung cancer is suspected. This simple test uses radiation to create pictures of your lungs and can reveal unusual masses or spots. However, X-rays have limitations—they may miss smaller tumors or provide insufficient detail about what’s seen.^[2]

A CT scan (computed tomography scan) is a more advanced imaging test that creates detailed, three-dimensional pictures of your lungs. The CT scanner is a large machine that rotates around you, taking multiple X-ray images from different angles. A computer then combines these images to produce cross-sectional views of your chest. CT scans are much more sensitive than regular X-rays and can detect tumors as small as a few millimeters. They also show the tumor’s exact size, location, and relationship to nearby structures like airways, blood vessels, and lymph nodes.^[2]

PET scans (positron emission tomography scans) use a small amount of radioactive sugar solution that’s injected into your vein. Cancer cells, which grow quickly and use more energy than normal cells, absorb more of this radioactive sugar. The PET scanner then detects this radioactivity and creates images showing areas of high metabolic activity. PET scans help determine whether cancer has spread to lymph nodes or other parts of the body. Often, PET scans are combined with CT scans in one examination to provide both structural and functional information.^[2]

MRI scans (magnetic resonance imaging) of the brain may be performed if there’s concern that cancer might have spread to the brain. MRI uses powerful magnets and radio waves instead of radiation to create detailed images of soft tissues.^[2]

Bronchoscopy

Bronchoscopy is a procedure that allows doctors to look directly inside your airways. During this test, a thin, flexible tube with a tiny camera on the end (called a bronchoscope) is passed through your nose or mouth, down your throat, and into your airways. The doctor can see the inside of your breathing passages and take small tissue samples if anything looks abnormal. This procedure is usually done with sedation to keep you comfortable. Bronchoscopy is particularly useful when tumors are located in the central airways.^[2]

Biopsy Procedures

A biopsy is the removal of a small piece of tissue for examination under a microscope. This is the definitive way to diagnose cancer because it allows a specialist called a pathologist to examine the cells directly and determine whether they are cancerous, what type of cancer it is, and other important characteristics. There are several ways to obtain a biopsy sample from lung tissue.^[2]

During bronchoscopy, the doctor can take tiny tissue samples from suspicious areas in your airways. If the tumor is located in the outer parts of the lung where the bronchoscope can’t reach, other biopsy methods may be needed. A needle biopsy can be performed by inserting a thin needle through the chest wall and into the lung tumor, guided by CT scan images to ensure accuracy.

Video-assisted thoracic surgery (VATS) is a minimally invasive surgical procedure where small incisions are made in the chest wall, and a tiny camera along with surgical instruments are inserted to view the lungs and take tissue samples. This approach provides a better look inside the chest than less invasive methods while avoiding the need for a large surgical incision.^[2]

Staging the Cancer

Once cancer is confirmed, doctors need to determine its stage—meaning how big the tumor is and whether it has spread. Stage I lung cancer means the tumor is relatively small (no larger than 4 centimeters, about the size of a walnut) and is only in the lung, with no cancer found in nearby lymph nodes or distant parts of the body.^[5]

Stage I is divided into substages to help doctors plan treatment more precisely. Stage IA tumors are 3 centimeters or smaller and are further classified as IA1, IA2, or IA3 based on their exact size. Stage IA1 tumors are 1 centimeter or less; stage IA2 tumors are between 1 and 2 centimeters; and stage IA3 tumors are between 2 and 3 centimeters. Stage IB means the tumor is larger than 3 centimeters but not more than 4 centimeters, or the tumor has grown into certain nearby structures but still hasn’t reached the lymph nodes.^[5]

This staging system uses what’s called TNM classification, which stands for Tumor, Node, and Metastasis. The T describes the size and location of the primary tumor, the N indicates whether cancer has spread to nearby lymph nodes, and the M shows whether cancer has spread to distant parts of the body. For stage I cancer, the tumor is present in the lung (T1 or T2), there is no lymph node involvement (N0), and there is no distant spread (M0).^[5]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or new ways of using existing treatments. They play a vital role in advancing cancer care and may offer access to cutting-edge therapies before they become widely available. However, to participate in a clinical trial, patients must meet specific eligibility criteria that are confirmed through diagnostic testing.^[3]

Standard diagnostic tests used to determine eligibility for clinical trials include all the imaging studies and biopsy procedures described above. Complete staging through CT scans and PET scans is essential because most trials specify which cancer stages they will accept. For stage I non-small cell lung cancer trials, documentation that the cancer hasn’t spread to lymph nodes or other organs is crucial.

Beyond basic staging, many clinical trials now require biomarker testing, also called molecular testing or genetic testing of the tumor. This involves analyzing the cancer cells from your biopsy to look for specific genetic changes or mutations (alterations in the DNA of cancer cells) that might make the tumor respond to particular targeted treatments. Common mutations tested include changes in genes called EGFR, ALK, ROS1, and others. The presence or absence of these mutations often determines whether you’re eligible for certain clinical trials.^[3]

Tests that measure your general health and organ function are also required before enrolling in trials. Blood tests check your liver and kidney function, blood cell counts, and other markers to ensure your body can handle the planned treatment. Some trials require lung function tests to measure how well your lungs work, particularly important if surgery or certain chemotherapy drugs are involved.

Your doctor may also assess your overall fitness level using a standardized scale. This helps determine whether you’re strong enough to participate in the trial and tolerate the experimental treatment. Trials typically exclude patients whose cancer has spread extensively or whose general health is too compromised.